Surgerii Robotics has secured $100.0 million in investment capital from investors. The Beijing-headquartered company, founded by Professor Kai Xu of Shanghai Jiao Tong University, is dedicated to becoming a global leader in high-tech medical devices. This funding round marks a significant milestone for Surgerii Robotics as it continues its mission to innovate surgery for better patient care through advanced robotic systems.
The company specializes in the research and development, manufacturing, and commercialization of minimally invasive surgical robotic systems and related products. Surgerii Robotics has notably developed a revolutionary single-port surgical robotic system, the culmination of nearly two decades of research. This system incorporates an innovative “Dual Continuum Mechanism,” utilizing flexible, nitinol-based snake-like instruments specifically tailored for single-port procedures, aiming to enhance surgical precision and patient outcomes.
The newly raised capital will be strategically deployed to accelerate Surgerii Robotics' ongoing research and development efforts, particularly in advancing its next-generation robotic platforms. Funds will also support the expansion of its manufacturing capabilities in Beijing and further strengthen its innovation center in Shanghai. A key focus for the investment will be the global commercialization of its single-port surgical robotic system, enabling the company to reach new markets and address the worldwide demand for high-quality medical technology.
This substantial investment underscores confidence in Surgerii Robotics' technological advancements and its potential to significantly impact the field of robotic surgery. With this funding, Surgerii Robotics is well-positioned to execute its global strategy, driving innovation and expanding access to advanced surgical care across the globe. The company aims to solidify its leadership in robotic surgery technology while continuing to address critical needs in global healthcare.
